Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.

Authors

Mehdi Nouraie
Deepika S. Darbari, George Washington University
Sohail Rana
Caterina P Minniti
Oswaldo L Castro
Lori Luchtman-Jones
Craig Sable, George Washington University
Niti Dham, George Washington University
Gregory J Kato
Mark T Gladwin
Gregory Ensing
Manuel Arteta
Andrew Campbell, George Washington University
James G Taylor
Sergei Nekhai
Victor R Gordeuk

Document Type

Journal Article

Publication Date

7-1-2020

Journal

American Journal of Hematology

Volume

95

Issue

7

Inclusive Pages

766-774

DOI

10.1002/ajh.25799

Keywords

Adolescent; Adult; Anemia, Sickle Cell; Biomarkers; Child; Child, Preschool; Disease-Free Survival; Female; Ferritins; Follow-Up Studies; Humans; Leukocyte Count; Male; Neutrophils; Prospective Studies; Survival Rate; Tricuspid Valve Insufficiency; United States; Young Adult

Comments

Epub 2020 Apr 21

APA Citation

Nouraie, M., Darbari, D. S., Rana, S., Minniti, C., Castro, O., Luchtman-Jones, L., Sable, C., Dham, N., Kato, G., Gladwin, M., Ensing, G., Arteta, M., Campbell, A., Taylor, J., Nekhai, S., & Gordeuk, V. (2020). Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.. American Journal of Hematology, 95 (7). http://dx.doi.org/10.1002/ajh.25799

Peer Reviewed

1